1'-(tert-Butoxycarbonyl)-1,4'-bipiperidine-4-methanol, 97.0%, 1g

3-bromo-5-propyl-1,2,4-oxadiazole, 95.0%, 1g

4-(1,3,5-Triaza-7-phosphaadamantan-1-ium-1-yl)butane-1-sulfonate, 98%, 1g

(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 25g

N-(4-methylpyrimidin-2-yl)thiourea, 95.0%, 500mg

2,4-DIIODOPYRIDIN-3-OL, 95.0%, 100mg

Acide 3-méthylsalicylique, min 98,5 %, pour la synthèse, 500 g, emballage en verre

(2-Amino-3-methoxyphenyl)methanol, 95.0%, 1g

2-(3-Butyn-1-yloxy)acetic acid, 100mg

2-Chloro-3-methoxypyridine, 99.00%, 500g

Didecyl Phosphate>95.0%(T)100mg

4-BENZYLIDENEAMINOPHENOL, 95%, 25g

2,2,2-Trifluoroethylamine Hydrochloride>98.0%(N)(T)25g